Flunixin for Koi Fish: Uses, Dosing & Pain-Control Risks

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Flunixin meglumine is a prescription nonsteroidal anti-inflammatory drug (NSAID). In veterinary medicine, it is used to reduce pain, inflammation, and fever. In koi and other fish, it is not a routine at-home pond medication. Instead, it is a veterinarian-directed drug used in selected cases where pain control is needed and the fish can be accurately weighed, examined, and monitored.

In the United States, flunixin products such as Banamine are approved for species like horses and cattle, not for koi. That means use in ornamental fish is generally an extra-label veterinary decision. Fish pain control is also an area where evidence is still developing. Reviews of fish analgesia note that flunixin has been used in some species, but published proof of consistent pain relief in fish remains limited. Because of that, your vet may choose flunixin in some cases, but may also recommend other pain-control plans depending on the procedure, water temperature, kidney function, and the overall health of your koi.

For pet parents, the biggest takeaway is this: flunixin is a professional-use medication, not a pond additive and not a medication to try based on mammal dosing advice. Small dosing errors matter in fish, and stressed or sick koi can decompensate quickly if the wrong drug, route, or concentration is used.

Your vet may consider flunixin for short-term inflammatory pain in koi. Examples can include discomfort associated with wound care, ulcer treatment, biopsy, surgical procedures, traumatic injury, or other hands-on treatments where tissue inflammation is expected. In some aquatic practices, flunixin has also been used as part of a broader anesthesia and recovery plan rather than as a stand-alone medication.

That said, flunixin does not treat the underlying cause of most koi illnesses. If a koi has an ulcer, for example, pain control may help comfort, but the fish may still need diagnostics, water-quality correction, sedation, debridement, culture, parasite testing, or targeted antimicrobial treatment. Pain medication is one piece of care, not the whole plan.

Evidence in fish is mixed. A published review found that flunixin has been studied in species such as rainbow trout, and routine use has been reported in some aquarium settings, but clear analgesic benefit has not been shown consistently across fish studies. That is why your vet may frame flunixin as an option rather than a guaranteed first-line choice for every painful koi condition.

There is no universal at-home koi dose that is safe to use without veterinary guidance. Published fish literature shows a wide range of flunixin use depending on species, route, and clinical goal. A review of fish analgesia reported routine intramuscular use around 0.25-0.5 mg/kg IM in some aquarium settings, while research in tilapia used 2.2 mg/kg IM for pharmacokinetic study purposes. Those numbers should not be treated as interchangeable koi instructions. Species differences, water temperature, sedation status, and illness severity can all change how a fish handles a drug.

In practice, your vet usually needs an accurate body weight, a planned route of administration, and a clear reason for treatment before choosing a dose. Injectable dosing is typically calculated in mg/kg, then converted to a very small volume based on the product concentration. Banamine injectable solution is commonly supplied as 50 mg/mL, so even a large koi may require only a tiny measured amount. That is one reason dosing mistakes happen so easily when people try to medicate fish without veterinary help.

Your vet may also adjust the plan if your koi is dehydrated, weak, recovering from anesthesia, or has suspected kidney compromise. Repeated NSAID dosing can raise risk. If your koi needs more than brief pain support, your vet may discuss a different analgesic strategy, additional monitoring, or whether the underlying disease process needs a different treatment priority.

Like other NSAIDs, flunixin can cause serious adverse effects if the dose is too high, the drug is repeated too often, or the fish is already medically fragile. In veterinary species broadly, NSAIDs are associated with gastrointestinal irritation or ulceration, kidney injury, and liver-related adverse effects. Fish-specific evidence is more limited, but reviews note concern for nephrotoxicity and hepatotoxicity with chronic NSAID exposure in aquatic animals.

In koi, side effects may be subtle. You may not see vomiting or diarrhea the way you would in a dog or cat. Instead, pet parents may notice worsening lethargy, poor balance, reduced feeding, increased bottom-sitting, abnormal gill movement, failure to recover normally after handling, or a general decline after treatment. These signs are not specific to flunixin, but they are reasons to contact your vet promptly.

See your vet immediately if your koi becomes severely weak, rolls, stops eating after treatment, shows marked respiratory effort, or declines after an injection or procedure. Because fish hide illness well, any downturn after NSAID use should be taken seriously. Supportive care may need to focus on water quality, oxygenation, sedation recovery, and the underlying disease process as much as the medication itself.

Flunixin should be used carefully with other NSAIDs or corticosteroids because combining anti-inflammatory drugs can increase the risk of ulceration, kidney stress, and other toxic effects. In practical koi medicine, that means your vet needs to know about every recent injection, medicated feed, bath treatment, or compounded medication your fish has received before adding flunixin.

NSAIDs can also be more risky in animals with dehydration, poor perfusion, kidney compromise, or liver disease. In koi, those problems may develop alongside transport stress, poor water quality, severe infection, or prolonged anorexia. Even if another drug is not a direct chemical interaction, the fish's condition can make flunixin less safe.

Because ornamental fish medicine often involves sedation, topical procedures, antibiotics, and water treatments used close together, your vet may space medications out or avoid flunixin entirely if the overall plan already carries kidney or recovery risk. Never combine flunixin with another pain reliever unless your vet has specifically built that protocol for your koi.